Overcoming Challenges in Infectious Diseases
Discover the latest medical research on the prevention, management and treatment of infectious diseases.
LATEST TOPICS
-
CDC updates treatment guidelines for gonococcal infection9 February, 2021Gonorrhoea – caused by infection with the Neisseria gonorrhoeae bacterium – affects approximately 106.1 million people annually, with rates of infection increasing steadily over the last few... -
Vietnam: Management of macrolide resistance in cases of community-acquired pneumonia28 January, 2021Dr NguyễnHứa Quang Head of Respiratory Department, Da Nang Hospital Da Nang City, Vietnam The 2019 American Thoracic Society/Infectious Diseases Society of America (ATS/IDSA) clinical... -
Routine molecular point-of-care testing improves influenza detection in hospitalised adults14 January, 2021The multicentre, open-label, randomised controlled trial evaluating the molecular point-of-care test-and-treat strategy for influenza (FluPOC) has shown that the routine use of this strategy... -
Management of urinary tract infection: Antibiotic selection18 December, 2020Professor Zheng Bo Deputy director of Institute of Clinical Pharmacology, Peking University Professor and Chief Physician of Peking University First Hospital Doctoral supervisor ... -
Management of bronchiectasis: An overview9 December, 2020Dr IP Kar Shun Simon Consultant in Respiratory Medicine Hong Kong Baptist Hospital Hong Kong The British Thoracic Society (BTS) guidelines for bronchiectasis in adults recommend patients... -
Quinolones: Historical development and use8 December, 2020Professor Shi Yi Jinling Hospital Affiliated to the Medical School of Nanjing University Department of Respiratory and Acute Illnesses Professor, chief physician, doctoral supervisor,... -
Fluoroquinolones and the risk of aortic aneurysm or aortic dissection6 December, 2020Professor Jiun-Ling Wang Medical Doctor and Associate Professor Department of Internal Medicine National Cheng Kung University Hospital Taiwan Observational studies1-4 have shown more than... -
COVID-19 and community-acquired pneumonia (CAP): The Hong Kong perspective2 December, 2020Dr Wilson Lam Specialist in Infectious Disease, Chiron Healthcare Group; Honorary Clinical Associate Professor, The Chinese University of Hong Kong (CUHK); Honorary Clinical Assistant... -
CDC updates recommendations for Staphylococcus aureus in NICU30 November, 2020Staphylococcus aureus remains a frequent source of infection in neonates, particularly affecting premature and critically ill infants.1 While infants may acquire S. aureus as part of their normal... -
Epidemiology, aetiology, and management of community-acquired pneumonia (CAP) in Hong Kong19 November, 2020Dr LAM Bing Director, Respiratory Medicine Centre Hong Kong Sanatorium Hospital Hong Kong In Asia, community-acquired pneumonia (CAP) causes almost one million deaths in adults annually.1...
CONTENT LIBRARY
CONTENT LIBRARY
INTERVIEWS
-
Vietnam: Management of macrolide resistance in cases of community-acquired pneumonia -
Management of urinary tract infection: Antibiotic selection -
Management of bronchiectasis: An overview -
Quinolones: Historical development and use -
Fluoroquinolones and the risk of aortic aneurysm or aortic dissection -
COVID-19 and community-acquired pneumonia (CAP): The Hong Kong perspective -
Epidemiology, aetiology, and management of community-acquired pneumonia (CAP) in Hong Kong -
Therapeutic strategies for community-acquired pneumonia (CAP) during the coronavirus disease 2019 (COVID-19) pandemic -
Insights into the updated World Health Organization guidelines for multi-drug-resistant tuberculosis -
Managing rational use of antimicrobials